|
1
|
Stewart BW and Kleihues P: World cancer
report. World Cancer Rep. 45:12–351. 2003.
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siddiqui JA, Singh A, Chagtoo M, Singh N,
Godbole MM and Chakravarti B: Phytochemicals for breast cancer
therapy: Current status and future implications. Curr Cancer Drug
Targets. 15:116–135. 2015. View Article : Google Scholar
|
|
4
|
García E, Marcos-Gutiérrez C, del Mar
Lorente M, Moreno JC and Vidal M: RYBP, a new repressor protein
that interacts with components of the mammalian Polycomb complex,
and with the transcription factor YY1. EMBO J. 18:3404–3418. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang W, Qin JJ, Voruganti S, Nag S, Zhou J
and Zhang R; Polycomb Group. Polycomb Group (PcG) proteins and
human cancers: Multifaceted functions and therapeutic implications.
Med Res Rev. 35:1220–1267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen D, Zhang J, Li M, Rayburn ER, Wang H
and Zhang R: RYBP stabilizes p53 by modulating MDM2. EMBO Rep.
10:166–172. 2009. View Article : Google Scholar :
|
|
7
|
Sánchez-Beato M, Sánchez E,
González-Carreró J, Morente M, Díez A, Sánchez-Verde L, Martín MC,
Cigudosa JC, Vidal M and Piris MA: Variability in the expression of
polycomb proteins in different normal and tumoral tissues. A pilot
study using tissue microarrays. Mod Pathol. 19:684–694. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang W, Cheng J, Qin JJ, Voruganti S, Nag
S, Fan J, Gao Q and Zhang R: RYBP expression is associated with
better survival of patients with hepatocellular carcinoma (HCC) and
responsiveness to chemotherapy of HCC cells in vitro and in vivo.
Oncotarget. 5:11604–11619. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Novak RL and Phillips AC:
Adenoviral-mediated Rybp expression promotes tumor cell-specific
apoptosis. Cancer Gene Ther. 15:713–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lando M, Holden M, Bergersen LC, Svendsrud
DH, Stokke T, Sundfør K, Glad IK, Kristensen GB and Lyng H: Gene
dosage, expression, and ontology analysis identifies driver genes
in the carcinogenesis and chemoradioresistance of cervical cancer.
PLoS Genet. 5:e10007192009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Voruganti S, Xu F, Qin JJ, Guo Y, Sarkar
S, Gao M, Zheng Z, Wang MH, Zhou J, Qian B, et al: RYBP predicts
survival of patients with non-small cell lung cancer and regulates
tumor cell growth and the response to chemotherapy. Cancer Lett.
369:386–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee NS, Evgrafov OV, Souaiaia T, Bonyad A,
Herstein J, Lee JY, Kim J, Ning Y, Sixto M, Weitz AC, et al:
Non-coding RNAs derived from an alternatively spliced REST
transcript (REST-003) regulate breast cancer invasiveness. Sci Rep.
5:112072015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
15
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013. View Article : Google Scholar
|
|
16
|
Lee YJ, Lin WL, Chen NF, Chuang SK and
Tseng TH: Demethylwedelolactone derivatives inhibit invasive growth
in vitro and lung metastasis of MDA-MB-231 breast cancer cells in
nude mice. Eur J Med Chem. 56:361–367. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suetsugu A, Honma K, Saji S, Moriwaki H,
Ochiya T and Hoffman RM: Imaging exosome transfer from breast
cancer cells to stroma at metastatic sites in orthotopic nude-mouse
models. Adv Drug Deliv Rev. 65:383–390. 2013. View Article : Google Scholar
|
|
18
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Giacinti C and Giordano A and Giordano A:
RB and cell cycle progression. Oncogene. 25:5220–5227. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koliadi A, Nilsson C, Holmqvist M,
Holmberg L, de La Torre M, Wärnberg F and Fjällskog ML: Cyclin B is
an immunohistochemical proliferation marker which can predict for
breast cancer death in low-risk node negative breast cancer. Acta
Oncol. 49:816–820. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niméus-Malmström E, Koliadi A, Ahlin C,
Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F,
Blomqvist C, Fernö M, et al: Cyclin B1 is a prognostic
proliferation marker with a high reproducibility in a
population-based lymph node negative breast cancer cohort. Int J
Cancer. 127:961–967. 2010.
|
|
22
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar
|
|
23
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Palena C, Roselli M, Litzinger MT, Ferroni
P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI,
Hamilton DH, et al: Overexpression of the EMT driver brachyury in
breast carcinomas: Association with poor prognosis. J Natl Cancer
Inst. 106:1062014. View Article : Google Scholar
|
|
25
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiao W, Miyazaki K and Kitajima Y: Inverse
correlation between E-cadherin and Snail expression in
hepatocellular carcinoma cell lines in vitro and in vivo. Br J
Cancer. 86:98–101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosivatz E, Becker KF, Kremmer E, Schott
C, Blechschmidt K, Höfler H and Sarbia M: Expression and nuclear
localization of Snail, an E-cadherin repressor, in adenocarcinomas
of the upper gastrointestinal tract. Virchows Arch. 448:277–287.
2006. View Article : Google Scholar
|
